BCHE and early-onset autosomal dominant Alzheimer disease: Furthermore, the anticholinesterase efficacy of the ligands was carried out where the molecular docking using the Schrodinger Maestro suit identified the ligand-binding pockets (sites) and conformation of the targets in the receptors using donepezil (a cholinesterase inhibitor used to manage ‘Alzheimer’s disease) (Table 5).